Big Pharma Split (TSX:PRM) Cash Flow for Dividends: C$-2.12 Mil (TTM As of Dec. 2025)


TSX:PRM Big Pharma Split Corp TSX:PRM
7 GF Score
Price C$11.61
GF Value C$1.80
View Full Analysis

What is Big Pharma Split Cash Flow for Dividends?

Big Pharma Split TSX:PRM 7 Cash Flow for Dividends is C$-2.12 Mil as of Dec. 2025. GuruFocus rates TSX:PRM with a GF Score™ of 7/100 and a GF Value™ of C$1.80.

Big Pharma Split's cash flow for dividends for the six months ended in Dec. 2025 was C$-1.10 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was C$-2.12 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Big Pharma Split's quarterly payment of dividends increased from Dec. 2024 (C$-0.98 Mil) to Jun. 2025 (C$-1.02 Mil) and increased from Jun. 2025 (C$-1.02 Mil) to Dec. 2025 (C$-1.10 Mil).

Big Pharma Split's annual payment of dividends declined from Dec. 2023 (C$-2.11 Mil) to Dec. 2024 (C$-2.04 Mil) but then increased from Dec. 2024 (C$-2.04 Mil) to Dec. 2025 (C$-2.12 Mil).

Big Pharma Split Cash Flow for Dividends Related Terms

Big Pharma Split Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Big Pharma Split's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split Cash Flow for Dividends Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only -2.84 -2.62 -2.11 -2.04 -2.12

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.99 -1.06 -0.98 -1.02 -1.10
TSX:PRM
7GF Score
Big Pharma Split Corp TSX:PRM
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Big Pharma Split Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was C$-2.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of C$-2.12 Mil mean?
Big Pharma Split (TSX:PRM) has a Cash Flow for Dividends of C$-2.12 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Big Pharma Split and its competitors.
Is Big Pharma Split's Cash Flow for Dividends too high?
Big Pharma Split's current Cash Flow for Dividends is C$-2.12 Mil. Overall, Big Pharma Split has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Big Pharma Split's Cash Flow for Dividends compare to BLK and BX?
Big Pharma Split's Cash Flow for Dividends of C$-2.12 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for an Asset Management company?
A good Cash Flow for Dividends depends on the Asset Management industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Big Pharma Split and its competitors. Big Pharma Split's current Cash Flow for Dividends is C$-2.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Big Pharma Split stock overvalued right now?
Big Pharma Split (TSX:PRM) has a current Cash Flow for Dividends of C$-2.12 Mil. The stock's GF Value™ is C$1.80, compared to a current price of C$11.61 — trading 545% above its estimated fair value. The current Cash Flow for Dividends is C$-2.12 Mil. Big Pharma Split's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Big Pharma Split (TSX:PRM), the current Cash Flow for Dividends is C$-2.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Big Pharma Split (TSX:PRM) Overvalued in 2026?

Based on GuruFocus' analysis, Big Pharma Split stock appears to be overvalued. The current stock price of C$11.61 is trading 545% above its estimated GF Value™ of C$1.80.

Key valuation signals for TSX:PRM:

  • Cash Flow for Dividends: C$-2.12 Mil
  • GF Value™: C$1.80 vs. price of C$11.61 (545% above fair value)
  • GF Score™: 7/100

No single metric tells the full story. See the TSX:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Big Pharma Split Business Description

Other Exchanges PRM.PR.A.PFD:Canada
Address 610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a closed end mutual fund corporation. The investment objective of the company is to provide shareholders with fixed cumulative preferential quarterly cash distributions and regular monthly cash distributions. The company has a presence in the United States, France, and the United Kingdom.
7GF Score

Get the complete analysis for TSX:PRM

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$11.61
Price
C$1.80
GF Value